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T
ransplant professionals are entrusted 
with a unique position in the prac-
tice of medicine—the stewardship of 
the organs from either the deceased or living 
donor. This stewardship entails two major 
responsibilities for which society holds trans-
plant professionals accountable: the equitable 
allocation of deceased donor organs to medi-
cally suitable recipients, and the evaluation 
and care for the living organ donor. Data, 
experience and ethical principles relevant to 
organ transplantation become invaluable in 
fulfilling these responsibilities and they are 
presented in this Editorial.
THE DECLARATION OF ISTANBUL
The policies regarding the allocation of or-
gans now have reference guides published in 
the medical literature as a resource for prac-
ticing transplant professionals. For example, 
the Declaration of Istanbul emphasizes that 
organs for transplantation should be equitably 
allocated within countries or jurisdictions to 
suitable recipients regardless of gender, eth-
nicity, religion, social or financial status. Fi-
nancial considerations or material gain of any 
party must not influence the application of rel-
evant allocation rules.
WHO GUIDING PRINCIPLES
The Declaration of Istanbul was followed by 
the development of guidelines of practice by 
the WHO that also address the allocation of 
organs. Guiding Principle 9 states that “the 
allocation of organs, cells and tissues should 
be guided by clinical criteria and ethical 
norms, not financial or other considerations. 
Allocation rules defined by properly constitut-
ed committees should be equitable, externally 
justified, and transparent.”
THE FINAL RULE IMPLEMENTED BY 
THE UNITED NETWORK FOR ORGAN 
SHARING (UNOS)
A framework termed the Final Rule for the 
structure and operation of the Organ Pro-
curement Transplant Network (OPTN) in the 
United States has been contracted to a private 
organization, the United Network for Organ 
Sharing (UNOS). The OPTN Final Rule 
gives the OPTN Board of Directors responsi-
bility for developing policies for the OPTN in 
specific areas:
•  Equitable allocation of  deceased donor 
organs,
•  Testing of  organ donors and follow-up of  
transplant recipients to prevent the spread 
of  infectious diseases,
•  Reducing inequities resulting from 
socioeconomic status, and
•  The training and experience of  transplant 
surgeons and transplant physicians in 
designated transplant programs.
The Department of Health and Human Ser-
vices directed the OPTN/UNOS to set pri-
orities for ranking candidates on the waitlist 
based upon measurable medical criteria and 
ordered by medical need. Section 121.8 of the 42 Int J Org Transplant Med 2013; Vol. 4 (2)    www.ijotm.com 
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Final Rule addresses the allocation of organs 
and states that allocation policies: The alloca-
tion
•  Shall be based upon sound medical 
judgment,
•  Shall seek to achieve the best use of  donated 
organs,
•  Shall preserve the ability of  a transplant 
program to decline an offer for a specific 
potential recipient,
•  Shall be designed to avoid wasting organs, 
avoid futile transplants and promote patient 
access to transplantation and efficient 
management of  organ placement,
•  Shall not be based upon the candidate’s 
place of  residence or place of  listing.
ALLOCATION PERFORMANCE GOALS 
AND ASSESSMENT OF PERFORMANCE 
The OPTN Final Rule includes performance 
goals for allocation policies. In addition to the 
use of objective and measurable medical crite-
ria, the policies provide for candidate rankings 
that give priority to patients based upon medi-
cal urgency with patients having the most 
urgent need receiving highest priority. Each 
organ-specific allocation policy should include 
performance indicators, determining by data 
on how closely the results of the current allo-
cation policy approach the performance goals; 
and thus, assure the public that ethical prin-
ciples are being upheld.
An important factor for the OPTN in its policy 
development deliberation, is the fact that the 
National Organ Transplant Act (NOTA) lim-
its the policy considerations for organ alloca-
tion policy to medical criteria. The Final Rule 
amplifies this restriction by requiring that the 
patient rankings, resulting from the allocation 
policy, be based upon objective and measurable 
medical criteria. Therefore, allocation policies 
do not take into account social criteria such as 
social worth or economic criteria. Organ al-
location policy does not consider, for example, 
whether a patient is an unemployed vagrant as 
opposed to the CEO of a major corporation. 
Likewise, the underlying cause of a disease 
such as drug or alcohol addiction is not con-
sidered by the allocation policies. An individ-
ual transplant program may consider whether 
a patient has maintained a suitable period of 
abstinence as part of its evaluation of whether 
the patient is an acceptable candidate, but once 
a patient is on the OPTN waiting list, whether 
the patient’s disease was caused by substance 
abuse may not be considered because it is un-
derstood to be “social criteria.”
APPLICATION OF ETHICAL PRINCIPLES
In the setting of the Final Rule, classic ethi-
cal principles of justice, utility, benefits, and 
non-maleficence and autonomy become evi-
dent. The Final Rule accounts for the justice 
principle by requiring allocation policy to be 
based upon sound medical judgment. Justice 
calls for the distribution of kidneys to patients 
with the longest waiting time. Ultimately, 
all patients with the same medical condition 
should be treated the same when placed on 
the waitlist. For extra-renal organs, the jus-
tice principle now mandates medical need or 
the severity of the patient’s illness as the fore-
most criterion of allocation. Utility, as an ethi-
cal principle of the Final Rule, seeks the best 
use of the donated organ in achieving the best 
allograft survival; the best outcome. Benefi-
cence promotes the interest of the patient to 
undergo transplantation. The Final Rule sus-
tains non-maleficence “to do no harm” by en-
abling a transplant center to decline a specific 
organ for a specific patient. Finally, autonomy 
preserves the ultimate decision of the patient 
to undergo transplantation. 
THE DEVELOPMENT OF A WAITLIST
Following these principles, local policies for 
organ allocation should be developed for pa-
tients on a waiting list that is applied with 
justice, utility and equity. Under its OPTN 
contract with Health Resources and Services 
Administration (HRSA), UNOS maintains a 
centralized computer network linking all or-
gan procurement organizations and transplant 
centers. This computer network is accessible www.ijotm.com    Int J Org Transplant Med 2013; Vol. 4 (2)  43
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24 hours a day, seven days a week. When a 
donated organ from a deceased donor is avail-
able, the Organ Procurement Organization 
(OPO) must enter information about the donor 
into the OPTN contractor’s computer system 
and execute the computer match program. 
That program will rank order the candidates 
on the OPTN waiting list according to the or-
gan allocation policies that have been adopted 
by the Board of Directors. Each patient in the 
database is matched by the computer against 
the donor characteristics. The computer then 
generates a ranked list of candidates for each 
available organ in ranked order according to 
OPTN organ allocation policies. The OPO 
then offers the organ to designated transplant 
programs in accordance to the rank order of 
the match. The transplant program may ac-
cept or refuse the offer. The match is patient-
specific as required by NOTA. The organ may 
not simply be offered to a transplant program 
for the program to use at its discretion. If an 
organ is offered to a transplant program for 
a certain patient, but the program decides to 
decline the offer, the organ is then offered to 
the next patient on the ranked OPTN match 
list even if the patient is at another institution. 
EUROTRANSPLANT
Eurotransplant is responsible for the alloca-
tion of donor organs in Austria, Belgium, Cro-
atia, Germany, Luxembourg, the Netherlands, 
and Slovenia. This international collaborative 
framework includes all transplant hospitals, 
tissue-typing laboratories and hospitals where 
organ donations take place. Eurotransplant 
was one of the first international organiza-
tions founded by Prof. Jon J. van Rood in 1967. 
The following is recorded at the Eurotrans-
plant Web site: all transplantation centers 
within the member states of Eurotransplant 
have access to the central computer database. 
In this database, the transplantation centers 
enter the general and medical information of 
their recipients along with the recipient pro-
file and the donor profile. As soon as a donor 
becomes available within the Eurotransplant 
area, the regional tissue-typing laboratory 
determines the donor’s blood group and tis-
sue characteristics. Eurotransplant generates 
a so-called “match list” for each donor organ, 
which in effect addresses a single waitlist of 
patients within the serviced countries. 
The match list is generated by a computer al-
gorithm that takes into account all medical 
and ethical criteria and is based upon the ex-
pected outcome and the medical urgency of a 
certain patient.
The allocation system of Eurotransplant has 
the following attributes:
•  Objective: the match list is the same no 
matter which duty desk officer arranges the 
allocation.
•  Reproducible: the same question will lead 
to the same answer.
•  Transparent: every step in the process can 
be accounted for. And,
•  Valid: the system is based upon valid medical 
and ethical criteria that are supported by 
consensus within the transplant community.
SOLICITATION FOR ORGAN DONORS
Another important principle of the WHO that 
was adopted by the 63rd World Health Assem-
bly in 2010 addresses solicitation of organs 
in the background of ethically proper alloca-
tion. Guiding principle 6 states that “advertis-
ing the need for or availability of cells, tissues 
or organs, with a view to offering or seeking 
payment to individuals for their cells, tissues 
or organs or to the next of kin where the in-
dividual is deceased, should be prohibited. 
Brokering that involves payment to such in-
dividuals or to 3rd parties should also be pro-
hibited.” The WHO goes on to state further 
“that this principle does not affect general ad-
vertisements or public appeals to encourage 
altruistic donation, provided they do not sub-
vert legally establish systems of organ dona-
tion.” In the United States, and elsewhere in 
the world, there have been billboards and me-
dia advertisements by those in need of trans-
plants attempting to bring public attention to 
their plight. UNOS has develop an important 
policy regarding billboard advertisements for 44 Int J Org Transplant Med 2013; Vol. 4 (2)    www.ijotm.com 
deceased donors, the way an individual may 
establish a relationship with a potential living 
donor, and the opportunity for directed dona-
tion when deceased donor allocation is consid-
ered. 
UNOS makes a distinction between solicita-
tions for live donor organ vs. solicitations for 
directed donation of deceased organs. Solicita-
tion for live donor organs is well known and 
pleas are being made today via the Internet. 
These Internet interactions are a matter of 
personal choice to convey medical and so-
cial information to potential vast audience in 
hopes of receiving a transplant. Aside from the 
Internet, appeals can also be made in a variety 
of other ways that enable personal relationship 
develop and result in the donation of an or-
gan from a living person to a specific recipi-
ent. Regulatory authorities should not restrict 
the ways relationships are developed with 
respect to live organ donation while uphold-
ing the provisions of WHO standards that it 
is unethical and widely illegal for any person 
to acquire a human organ for transplantation 
on the basis of monetary compensation to a 
vendor. Transplant centers also have a respon-
sibility in helping protect potential recipients 
from the hazards that can arise from public 
appeals. The psychosocial evaluation of live 
donors should assess the motivation of these 
individuals to make certain that they will not 
be imposing upon the organ transplant recipi-
ent for the duration of their life.
Regarding public solicitation for deceased do-
nor organs, regulatory authorities should es-
tablish policy regarding the appropriateness 
of donor-donee relationship in directed dona-
tions from deceased donors. Any relationship 
forms via public or commercial solicitation, for 
example by the use of billboards will under-
mine the public trust in the allocation system 
if certain patients are advantaged to receive 
the next available organ because of such com-
mercial solicitation.
DIRECTED DONATION
By my personal experience as medical direc-
tor of the New England Organ Bank (NEOB), 
and consistent with the policy of the OPTN/
UNOS regarding directed donation, the 
NEOB has participated in facilitating deceased 
organ donation by a person authorized to con-
sented donation when the following conditions 
are present:
•  The donate in the directed donation is a 
specific named individual.
•  There is no monetary exchange of  valuable 
consideration or other coercive inducement 
involved in the donation. And,
•  When relevant law of  a jurisdiction 
permits such directed donation (consistent 
with WHO guidelines).
The NEOB does not participate in donations 
which discriminate against the person or class 
of persons on the basis of race, national ori-
gin, religion, gender or any other such social 
characteristics. The NEOB contacts the ap-
propriate transplant center to describe the op-
portunity of directed donation from a specific 
donor intended for a specific potential recipi-
ent to determine medical suitability and medi-
cal preparedness to undergo transplantation. 
THE PUBLIC TRUST
The public trust is undermined when there is 
a violation of ethical principles in the imple-
mentation of the organ allocation system. So-
ciety will not donate if it has the impression 
that the national system of organ donation is 
corrupt. Media reports of such instances be-
come the source of concern and require soci-
etal attention as exercise through appropriate 
regulatory authority such as the Ministry of 
Health, etc. 
Organ allocation becomes a testimony of so-
cial justice within a country or jurisdiction. No 
culture of the world rejects the opportunity of 
medical treatment by organ transplantation. 
No culture of the world should then reject or-
gan donation from the deceased. Conversely, 
no society can sustain a system of deceased 
organ donation if those that donate cannot be 
recipients within that country or jurisdiction. 
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The WHO has promulgated the most impor-
tant concluding guideline of transparency, i.e., 
“the organization and execution of donation 
and transplantation activities, as well as their 
clinical results must be transparent and open 
to scrutiny, while ensuring that personal ano-
nymity and privacy of donors and recipients 
are always protected.”
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